The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education
Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
AI-enabled women’s digital clinic brings in-person consultations to complement app-led care after serving over 400,000 women across India
In his new role, Karthik will lead human capital strategy and HR operations across these regions
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform
Subscribe To Our Newsletter & Stay Updated
